CD42a Antibodies

Santa Cruz Biotechnology offers a broad range of CD42a monoclonal antibodies for research focused on understanding platelet function and blood clotting mechanisms. CD42a monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD42a, also known as glycoprotein Ib alpha, is a key component of the von Willebrand factor receptor complex on platelets, playing a vital role in platelet adhesion and aggregation during hemostasis. Its function is crucial for maintaining normal blood clotting processes, and dysregulation of CD42a can lead to bleeding disorders or thrombotic conditions. Understanding CD42a mechanisms has significant implications for cardiovascular disease research and treatment development. CD42a expression patterns can be effectively analyzed across various tissue types and experimental conditions. Researchers can explore CD42a's role in platelet-vessel wall interactions and thrombus formation. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies targeting CD42a support researchers worldwide in advancing our understanding of platelet biology and cardiovascular health.